Old Web
English
Sign In
Acemap
>
authorDetail
>
Mingxing Shi
Mingxing Shi
Zhengzhou University
Molecular medicine
Cancer research
Metformin
Ovarian cancer
MAPK/ERK pathway
1
Papers
25
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (1)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Metformin combined with p38 MAPK inhibitor improves cisplatin sensitivity in cisplatin-resistant ovarian cancer
2014
Molecular Medicine Reports
Ya Xie
Zheng Ping Peng
Mingxing Shi
Mei Ji
Hongjun Guo
Huirong Shi
Show All
Source
Cite
Save
Citations (25)
1